中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2012年
23期
7-8
,共2页
急性进展性脑梗死%疏血通注射液%尤瑞克林
急性進展性腦梗死%疏血通註射液%尤瑞剋林
급성진전성뇌경사%소혈통주사액%우서극림
Acute progressive cerebral infarction%Shuxuetong injection%Urinary kallidinogenase
目的:探讨疏血通注射液联合尤瑞克林治疗急性进展性脑梗死的临床疗效.方法:选取我院脑病科2011年3月~2012年3月期间收治的急性进展性脑梗死患者66例,随机将患者分为治疗组和对照组,治疗组34例,对照组32例.两组患者经明确诊断后均给予常规治疗,观察组在基础治疗以外加用疏血通注射液与尤瑞克林的联合用药方案,而对照组则在基础治疗以外仅给予疏血通注射液的药物治疗,并对两组间的临床治疗情况进行对比分析.结果:观察组与对照组相比,其患者经治疗后基本痊愈率和总有效率均显著提高,而无效率则显著降低,差别均具有统计学意义(P<0.05);其患者经治疗后的神经功能缺损评分显著增高,并且呈现出显著性差异(P<0.05).结论:疏血通注射液联合尤瑞克林治疗急性进展性脑梗死,临床治疗效果显著提高,且神经功能缺损评分情况显著改善,是急性进展性脑梗死患者较为理想的联合用药方案.
目的:探討疏血通註射液聯閤尤瑞剋林治療急性進展性腦梗死的臨床療效.方法:選取我院腦病科2011年3月~2012年3月期間收治的急性進展性腦梗死患者66例,隨機將患者分為治療組和對照組,治療組34例,對照組32例.兩組患者經明確診斷後均給予常規治療,觀察組在基礎治療以外加用疏血通註射液與尤瑞剋林的聯閤用藥方案,而對照組則在基礎治療以外僅給予疏血通註射液的藥物治療,併對兩組間的臨床治療情況進行對比分析.結果:觀察組與對照組相比,其患者經治療後基本痊愈率和總有效率均顯著提高,而無效率則顯著降低,差彆均具有統計學意義(P<0.05);其患者經治療後的神經功能缺損評分顯著增高,併且呈現齣顯著性差異(P<0.05).結論:疏血通註射液聯閤尤瑞剋林治療急性進展性腦梗死,臨床治療效果顯著提高,且神經功能缺損評分情況顯著改善,是急性進展性腦梗死患者較為理想的聯閤用藥方案.
목적:탐토소혈통주사액연합우서극림치료급성진전성뇌경사적림상료효.방법:선취아원뇌병과2011년3월~2012년3월기간수치적급성진전성뇌경사환자66례,수궤장환자분위치료조화대조조,치료조34례,대조조32례.량조환자경명학진단후균급여상규치료,관찰조재기출치료이외가용소혈통주사액여우서극림적연합용약방안,이대조조칙재기출치료이외부급여소혈통주사액적약물치료,병대량조간적림상치료정황진행대비분석.결과:관찰조여대조조상비,기환자경치료후기본전유솔화총유효솔균현저제고,이무효솔칙현저강저,차별균구유통계학의의(P<0.05);기환자경치료후적신경공능결손평분현저증고,병차정현출현저성차이(P<0.05).결론:소혈통주사액연합우서극림치료급성진전성뇌경사,림상치료효과현저제고,차신경공능결손평분정황현저개선,시급성진전성뇌경사환자교위이상적연합용약방안.
Objective: To investigate the clinical therapeutic effect of Shuxuetong injection combined with urinary kallidinogenase in treating acute progressive cerebral infarction. Methods: 66 cases of the patients with acute progressive cerebral infarction collected from March in 2011 to March in 2012 were randomly divided into two groups, 34 in the treatment group and 32 in the control group. After definite diagnosis both groups were given conventional therapy. Besides, the treatment group was treated with Shuxuetong injection combined with urinary kallidinogenase, while the control group was only given Shuxuetong injection. The clinical effects of the two groups were compared and analyzed. Results: Compared with the control group, the basic recovery rate and total effective rate of the treatment group after treatment increased significantly, and the inefficiency decreased significantly, both with significant differences (P<0.05). Scores of neurologic impairment of these patients after treatment increased notably, with a significant difference (P<0.05). Conclusion:Shuxuetong injection combined with urinary kallidinogenase was effective in treating acute progressive cerebral infarction, with predominate improvement in neurologic impairment. It was supposed to be an ideal medicine combination in treating acute progressive cerebral infarction
